These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17048059)

  • 1. Iron reduction therapy by phlebotomy reduces lipid peroxidation and oxidative stress in patients with chronic hepatitis C.
    Kaito M; Iwasa M; Kobayashi Y; Fujita N; Tanaka H; Gabazza EC; Adachi Y; Kojima Y; Nakagawa N; Watanabe S
    J Gastroenterol; 2006 Sep; 41(9):921-2. PubMed ID: 17048059
    [No Abstract]   [Full Text] [Related]  

  • 2. Additional effect of low iron diet on iron reduction therapy by phlebotomy for chronic hepatitis C.
    Kimura F; Hayashi H; Yano M; Yoshioka K; Matsumura T; Fukuda T; Shigeto N; Yamahara S; Koushi F; Mishima Y; Yoshino T; Tanimoto M; Kimura I
    Hepatogastroenterology; 2005; 52(62):563-6. PubMed ID: 15816478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalization of elevated hepatic 8-hydroxy-2'-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet.
    Kato J; Kobune M; Nakamura T; Kuroiwa G; Takada K; Takimoto R; Sato Y; Fujikawa K; Takahashi M; Takayama T; Ikeda T; Niitsu Y
    Cancer Res; 2001 Dec; 61(24):8697-702. PubMed ID: 11751387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamins B depletion, lower iron status and decreased antioxidative defense in patients with chronic hepatitis C treated by pegylated interferon alfa and ribavirin.
    Lin CC; Yin MC
    Clin Nutr; 2009 Feb; 28(1):34-8. PubMed ID: 19042060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study.
    Fargion S; Fracanzani AL; Rossini A; Borzio M; Riggio O; Belloni G; Bissoli F; Ceriani R; Ballarè M; Massari M; Trischitta C; Fiore P; Orlandi A; Morini L; Mattioli M; Oldani S; Cesana B; Fiorelli G
    Am J Gastroenterol; 2002 May; 97(5):1204-10. PubMed ID: 12014729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane.
    Konishi M; Iwasa M; Araki J; Kobayashi Y; Katsuki A; Sumida Y; Nakagawa N; Kojima Y; Watanabe S; Adachi Y; Kaito M
    J Gastroenterol Hepatol; 2006 Dec; 21(12):1821-5. PubMed ID: 17074020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of serum ALT normalization after phlebotomy in patients with chronic hepatitis C infection.
    Kawamura Y; Akuta N; Sezaki H; Hosaka T; Someya T; Kobayashi M; Suzuki F; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H
    J Gastroenterol; 2005 Sep; 40(9):901-6. PubMed ID: 16211347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial.
    Di Bisceglie AM; Bonkovsky HL; Chopra S; Flamm S; Reddy RK; Grace N; Killenberg P; Hunt C; Tamburro C; Tavill AS; Ferguson R; Krawitt E; Banner B; Bacon BR
    Hepatology; 2000 Jul; 32(1):135-8. PubMed ID: 10869301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phlebotomy, dietary iron restriction therapy and bovine lactoferrin therapy for chronic hepatitis C].
    Kaito M; Iwasa M; Adachi Y; Iwata K; Yamauchi K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):534-9. PubMed ID: 15359857
    [No Abstract]   [Full Text] [Related]  

  • 10. Iron depletion before HCV antiviral therapy: a pilot, randomized, controlled trial.
    Gentile I; Viola C; Paesano L; D'Onofrio M; D'Agostino E; Cerini R; Borrelli F; Piazza M; Borgia G
    J Clin Apher; 2009; 24(5):190-6. PubMed ID: 19760753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term effects of phlebotomy on biochemical and histological parameters of chronic hepatitis C.
    Yano M; Hayashi H; Wakusawa S; Sanae F; Takikawa T; Shiono Y; Arao M; Ukai K; Ito H; Watanabe K; Yoshioka K
    Am J Gastroenterol; 2002 Jan; 97(1):133-7. PubMed ID: 11808937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study of iron depletion as adjuvant therapy in chronic hepatitis C patients not responding to interferon.
    Guyader D; Boucher E; André P; Even C; Cottereau J; Bianchi A; Gasser P; Mendler MH; Deugnier Y; Brissot P
    Am J Gastroenterol; 1999 Jun; 94(6):1696-8. PubMed ID: 10364051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
    Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
    Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of iron in the natural history and clinical course of hepatitis C disease.
    Shedlofsky SI
    Hepatogastroenterology; 1998; 45(20):349-55. PubMed ID: 9638405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C.
    Kageyama F; Kobayashi Y; Kawasaki T; Toyokuni S; Uchida K; Nakamura H
    Am J Gastroenterol; 2000 Apr; 95(4):1041-50. PubMed ID: 10763957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of iron depletion on long-term response to interferon-alpha in patients with chronic hepatitis C who previously did not respond to interferon therapy.
    Tsai NC; Zuckerman E; Han SH; Goad K; Redeker AG; Fong TL
    Am J Gastroenterol; 1997 Oct; 92(10):1831-4. PubMed ID: 9382046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipid peroxidation and anti-oxidative protection in patients with chronic type C hepatitis].
    Mansurova FKh; Mutikhova KhSh; Olimova SO
    Klin Med (Mosk); 2005; 83(5):39-42. PubMed ID: 15984581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of oxidative stress markers is dependent on vitamin D levels in patients with chronic hepatitis C.
    de Almeida JP; Liberatti LS; Barros FE; Kallaur AP; Lozovoy MA; Scavuzzi BM; Panis C; Reiche EM; Dichi I; Simão AN
    Nutrition; 2016 Mar; 32(3):362-7. PubMed ID: 26847403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatic iron, iron depletion and response to therapy with peg-Interferon and Ribavirin in chronic hepatitis C. Pilot study].
    Bertino G; Ardiri AM; Boemi PM; Ierna D; Sciuto M; Cilio D; Pulvirenti D; Neri S
    Clin Ter; 2007; 158(5):391-5. PubMed ID: 18062344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temperature-dependent lipid peroxidation of rat brain homogenate.
    Miura T; Muraoka S; Fujimoto Y
    Res Commun Mol Pathol Pharmacol; 1998 Apr; 100(1):117-28. PubMed ID: 9644725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.